Younjee Chung Selected Research

Aftercare (After-Treatment)

1/2013

Neutron-activatable holmium-containing mesoporous silica nanoparticles as a potential radionuclide therapeutic agent for ovarian cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Younjee Chung Research Topics

Disease

2	Neoplasm Metastasis (Metastasis) 01/2013 - 04/2012
2	Ovarian Neoplasms (Ovarian Cancer) 01/2013 - 04/2012
2	Neoplasms (Cancer) 01/2013 - 04/2012
1	Myoma 01/2018

Drug/Important Bio-Agent (IBA)

2	HolmiumIBA 01/2013 - 04/2012
1	Radioisotopes (Radionuclides)IBA 01/2013
1	IsotopesIBA 01/2013
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2013

Therapy/Procedure

1	Uterine Myomectomy 01/2018
1	Therapeutics 01/2013
1	Aftercare (After-Treatment) 01/2013
1	Radiotherapy 04/2012
1	Intraperitoneal Injections 04/2012